SOL S.p.A
SOL S.p.A. engages in the applied research, production, and marketing of technical and medical gases in Italy and internationally. The company offers oxygen, nitrogen, argon, hydrogen, carbon and sulphur dioxide, acetylene, nitrous oxide, gas mixtures, high purity gases, food gases, gaseous and liquid helium, gas for electronics, ammonia and combustible gases, and liquefied natural gas. It also p… Read more
SOL S.p.A (0NJP) - Net Assets
Latest net assets as of : €- EUR
Based on the latest financial reports, SOL S.p.A (0NJP) has net assets worth €- EUR as of .
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€-) and total liabilities (€-). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €- |
| % of Total Assets | 0% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | N/A |
SOL S.p.A - Net Assets Trend (None–None)
This chart illustrates how SOL S.p.A's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for SOL S.p.A (None–None)
The table below shows the annual net assets of SOL S.p.A from None to None.
| Year | Net Assets | Change |
|---|---|---|
| No yearly data available. | ||
Equity Component Analysis
This analysis shows how different components contribute to SOL S.p.A's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- No equity composition insights available.
SOL S.p.A Competitors by Market Cap
The table below lists competitors of SOL S.p.A ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Regis Resources Ltd
PINK:RGRNF
|
$1.79 Billion |
|
Celldex Therapeutics Inc
NASDAQ:CLDX
|
$1.79 Billion |
|
Yunnan Wenshan Electric Power Co Ltd
SHG:600995
|
$1.79 Billion |
|
MULTIPLAN EMPREENDIMENTOS IMOB
PINK:MLTTY
|
$1.79 Billion |
|
Hycroft Mining Holding Corporation
NASDAQ:HYMC
|
$1.79 Billion |
|
Vietnam Dairy Products JSC
VN:VNM
|
$1.79 Billion |
|
Jiangsu Cnano Technology Co Ltd
SHG:688116
|
$1.79 Billion |
|
Softcat plc
F:SF5
|
$1.79 Billion |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in SOL S.p.A's equity between the two most recent reporting periods.
Insufficient data available to analyze equity growth attribution.
Book Value vs Market Value Analysis
This analysis compares SOL S.p.A's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Insufficient data available to analyze book value vs market value.
Capital Efficiency Dashboard
This dashboard shows how efficiently SOL S.p.A utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Insufficient data available to analyze capital efficiency metrics.
Industry Comparison
This section compares SOL S.p.A's net assets metrics with peer companies in the same industry.
Industry Context
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| SOL S.p.A (0NJP) | €- | N/A | N/A | $1.79 Billion |
| Nyfosa AB (0A0K) | $2.92 Billion | 39.50% | 2.88x | $973.31 Million |
| High Templar Tech Limited (0A2T) | $12.52 Billion | 4.70% | 0.13x | $255.82 Million |
| Strategy Inc (0A7O) | $51.04 Billion | -7.54% | 0.21x | $40.17 Billion |
| NACON SASU (0A9N) | $67.54 Million | 15.85% | 1.20x | $7.64 Million |
| Antin Infrastructure Partners (0AA5) | $23.79 Million | 108.98% | 1.09x | $573.10 Million |
| Truecaller AB Series B (0AA7) | $1.41 Billion | 18.30% | 0.20x | $281.60 Million |
| Brockhaus Technologies AG (0AAW) | $254.92 Million | -6.23% | 1.68x | $74.40 Million |
| Hyloris Pharmaceuticals S.A. (0AB6) | $48.06 Million | -24.09% | 0.32x | $71.96 Million |
| Kalray S.A. (0ABT) | $28.43 Million | -41.56% | 0.67x | $33.84 Million |
| Webuild S.p.A. (0BJP) | $1.43 Billion | 10.29% | 7.14x | $1.13 Billion |